ACE2: Targeting a Potentially Important Receptor in Disease Pathogenesis | CAS
Role of angiotensin-converting enzyme 2 in neurodegenerative diseases during the COVID-19 pandemic | Aging
Frontiers | The ACE2/Angiotensin-(1–7)/Mas Receptor Axis: Pleiotropic Roles in Cancer
Downregulation of ACE2 induces overstimulation of the renin–angiotensin system in COVID-19: should we block the renin–angiotensin system? | Hypertension Research
COVID‐19 and renin‐angiotensin system inhibition: role of angiotensin converting enzyme 2 (ACE2) ‐ Is there any scientific evidence for controversy? - Aleksova - 2020 - Journal of Internal Medicine - Wiley Online Library
Cardiovascular Medicine - SARS-CoV-2 und das Renin-Angiotensin-System: was wir wissen
ACE Inhibitor Pathway, Pharmacodynamics
SARS-CoV-2 and ACE2: The biology and clinical data settling the ARB and ACEI controversy - eBioMedicine
ACE2, a new regulator of the renin–angiotensin system: Trends in Endocrinology & Metabolism
Allosteric Site of ACE-2 as a Drug Target for COVID-19 | ACS Pharmacology & Translational Science
Mit löslichem ACE2 gegen COVID-19
Frontiers | The Lung, the Heart, the Novel Coronavirus, and the Renin- Angiotensin System; The Need for Clinical Trials
Pathways: ACE Inhibitor Pathway | www.antikoerper-online.de
IJMS | Free Full-Text | COVID-19 and RAS: Unravelling an Unclear Relationship
Role of the ACE2/Angiotensin 1–7 Axis of the Renin–Angiotensin System in Heart Failure | Circulation Research
Frontiers | Angiotensin Converting Enzyme 2 (ACE2) in Pregnancy: Preeclampsia and Small for Gestational Age
Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors—lessons from available evidence and insights into COVID-19 | Hypertension Research
ACE2 – From the renin–angiotensin system to gut microbiota and malnutrition - ScienceDirect
Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID19 | Signal Transduction and Targeted Therapy
What is the ACE2 receptor, how is it connected to coronavirus and why might it be key to treating COVID-19? The experts explain
Angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers in COVID-19 - The Centre for Evidence-Based Medicine
COVID-19 and ACE -inhibitors and angiotensin receptor blockers-: The need to differentiate between early infection and acute lung injury | Revista Colombiana de Cardiología
View of The regulation of ACE-2 in the heart and lungs | The Southwest Respiratory and Critical Care Chronicles
SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy
Angiotensin-Converting Enzyme II in the Heart and the Kidney | Circulation Research
